Rocket
Premium
Excel Add-In
International
Tools
Dashboard
Screener
Spinoffs
IPOs
Register
Alerts
Sign In
Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders
Insiders Menu
Roster
Transactions
ALPINE IMMUNE SCIENCES, INC. (NVLS)
Date
Name
Title
Type
Security
Shares
Price
Value
Ownership
Reported
10/02/2023
Dummer Wolfgang
Chief Medical Officer
Grant
Stock Option (Right to buy)
200k
$11.37
$2.3M
10/02/2023
01/05/2023
Sandler Andrew Seth
Chief Medical Officer
Grant
Stock Option (Right to buy)
50k
$0.00
$0
01/05/2023
01/04/2023
PENG STANFORD L
See Remarks
Grant
Stock Option (Right to buy)
150k
$0.00
$0
01/04/2023
01/04/2023
Rickey James Paul
See Remarks
Grant
Stock Option (Right to buy)
109k
$0.00
$0
01/04/2023
01/04/2023
GOLD MITCHELL
Executive Chairman and CEO
Grant
Stock Option (Right to buy)
350k
$0.00
$0
01/04/2023
01/03/2023
CONWAY ROBERT E
Director
Grant
Stock Option (Right to buy)
10k
$0.00
$0
01/03/2023
01/03/2023
Topper James N
Director
Grant
Stock Option (Right to buy)
10k
$0.00
$0
01/03/2023
01/03/2023
Thompson Peter A.
Director
Grant
Stock Option (Right to buy)
10k
$0.00
$0
01/03/2023
01/03/2023
Cui Xiangmin
10% Owner
Grant
Stock Option (Right to buy)
10k
$0.00
$0
01/03/2023
01/03/2023
Peetz Christopher
Director
Grant
Stock Option (Right to buy)
10k
$0.00
$0
01/03/2023
01/03/2023
Drappa Jorn
Director
Grant
Stock Option (Right to buy)
10k
$0.00
$0
01/03/2023
01/03/2023
Hernday Natasha
Director
Grant
Stock Option (Right to buy)
10k
$0.00
$0
01/03/2023
09/23/2022
Decheng Capital China Life Sciences USD Fund III, L.P.
10% Owner
Grant
Common Stock
639.5k
$7.35
$4.7M
09/23/2022
09/23/2022
Decheng Capital China Life Sciences USD Fund III, L.P.
10% Owner
Grant
Common Stock
1.4M
$7.35
$10M
See footnote
09/23/2022
09/23/2022
Cui Xiangmin
10% Owner
Grant
Common Stock
639.5k
$7.35
$4.7M
See Footnote
09/23/2022
09/23/2022
Cui Xiangmin
10% Owner
Grant
Common Stock
1.4M
$7.35
$10M
See Footnote
09/23/2022
08/17/2022
Sandler Andrew Seth
Chief Medical Officer
Grant
Stock Option (Right to buy)
160k
$8.38
$1.3M
08/17/2022
07/18/2022
Drappa Jorn
Director
Grant
Stock Option (Right to buy)
20k
$8.71
$174.2k
07/18/2022
07/15/2022
Venkatesan Jay
10% Owner
Exercise
Stock Option (Right to buy)
20.1k
$0.45
$9k
07/15/2022
02/11/2022
Frazier Life Sciences VIII, L.P.
10% Owner
Purchase
Common Stock
112.7k
$7.10
$800k
02/11/2022
01/04/2022
PENG STANFORD L
See Remarks
Grant
Stock Option (Right to buy)
215k
$0.00
$0
01/04/2022
01/04/2022
Rickey James Paul
See Remarks
Grant
Stock Option (Right to buy)
112.5k
$0.00
$0
01/04/2022
01/04/2022
GOLD MITCHELL
Executive Chairman and CEO
Grant
Stock Option (Right to buy)
215k
$0.00
$0
01/04/2022
01/03/2022
CONWAY ROBERT E
Director
Grant
Stock Option (Right to buy)
10k
$0.00
$0
01/03/2022
01/03/2022
Cui Xiangmin
10% Owner
Grant
Stock Option (Right to buy)
10k
$0.00
$0
01/03/2022
01/03/2022
Venkatesan Jay
10% Owner
Grant
Stock Option (Right to buy)
10k
$0.00
$0
01/03/2022
01/03/2022
Thompson Peter A.
Director
Grant
Stock Option (Right to buy)
10k
$0.00
$0
01/03/2022
01/03/2022
Topper James N
Director
Grant
Stock Option (Right to buy)
10k
$0.00
$0
01/03/2022
01/03/2022
Peetz Christopher
Director
Grant
Stock Option (Right to buy)
10k
$0.00
$0
01/03/2022
01/03/2022
Hernday Natasha
Director
Grant
Stock Option (Right to buy)
10k
$0.00
$0
01/03/2022
12/31/2021
Rickey James Paul
See Remarks
Sale
Common Stock
17k
$13.92
$236.8k
12/31/2021
09/23/2021
Peetz Christopher
Director
Purchase
Common Stock
1.9k
$10.17
$19.3k
Christopher Peetz and Christine Peetz TR UA 02/15/2017 The Peetz Living Trust
09/23/2021
09/23/2021
Peetz Christopher
Director
Sale
Common Stock
1.9k
$10.17
$19.3k
Christopher Peetz & Christine Peetz TR UA 02/15/2017 The Peetz Living Trust
09/23/2021
09/23/2021
CONWAY ROBERT E
Director
Sale
Common Stock
15k
$10.08
$151.2k
By Robert E. Conway Rev Trust and Carolyn J. Conway Rev Trust
09/23/2021
09/21/2021
CONWAY ROBERT E
Director
Purchase
Common Stock
10k
$9.80
$98k
By Robert E. Conway Rev Trust and Carolyn J. Conway Rev Trust
09/21/2021
Next >>
Rocket Data Systems, Inc. © 2019 |
Contact Us
|
Data Disclaimer
|
Terms of Use
|
Privacy